Cargando…

The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation

BACKGROUND: SUMOylation, as part of the epigenetic regulation of transcription, has been intensively studied in lower eukaryotes that contain only a single SUMO protein; however, the functions of SUMOylation during mammalian epigenetic transcriptional regulation are largely uncharacterized. Mammals...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Pei-Ching, Cheng, Chia-Yang, Campbell, Mel, Yang, Yi-Cheng, Hsu, Hung-Wei, Chang, Ting-Yu, Chu, Chia-Han, Lee, Yi-Wei, Hung, Chiu-Lien, Lai, Shi-Mei, Tepper, Clifford G, Hsieh, Wen-Ping, Wang, Hsei-Wei, Tang, Chuan-Yi, Wang, Wen-Ching, Kung, Hsing-Jien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046822/
https://www.ncbi.nlm.nih.gov/pubmed/24267727
http://dx.doi.org/10.1186/1471-2164-14-824
_version_ 1782480319588335616
author Chang, Pei-Ching
Cheng, Chia-Yang
Campbell, Mel
Yang, Yi-Cheng
Hsu, Hung-Wei
Chang, Ting-Yu
Chu, Chia-Han
Lee, Yi-Wei
Hung, Chiu-Lien
Lai, Shi-Mei
Tepper, Clifford G
Hsieh, Wen-Ping
Wang, Hsei-Wei
Tang, Chuan-Yi
Wang, Wen-Ching
Kung, Hsing-Jien
author_facet Chang, Pei-Ching
Cheng, Chia-Yang
Campbell, Mel
Yang, Yi-Cheng
Hsu, Hung-Wei
Chang, Ting-Yu
Chu, Chia-Han
Lee, Yi-Wei
Hung, Chiu-Lien
Lai, Shi-Mei
Tepper, Clifford G
Hsieh, Wen-Ping
Wang, Hsei-Wei
Tang, Chuan-Yi
Wang, Wen-Ching
Kung, Hsing-Jien
author_sort Chang, Pei-Ching
collection PubMed
description BACKGROUND: SUMOylation, as part of the epigenetic regulation of transcription, has been intensively studied in lower eukaryotes that contain only a single SUMO protein; however, the functions of SUMOylation during mammalian epigenetic transcriptional regulation are largely uncharacterized. Mammals express three major SUMO paralogues: SUMO-1, SUMO-2, and SUMO-3 (normally referred to as SUMO-1 and SUMO-2/3). Herpesviruses, including Kaposi’s sarcoma associated herpesvirus (KSHV), seem to have evolved mechanisms that directly or indirectly modulate the SUMO machinery in order to evade host immune surveillance, thus advancing their survival. Interestingly, KSHV encodes a SUMO E3 ligase, K-bZIP, with specificity toward SUMO-2/3 and is an excellent model for investigating the global functional differences between SUMO paralogues. RESULTS: We investigated the effect of experimental herpesvirus reactivation in a KSHV infected B lymphoma cell line on genomic SUMO-1 and SUMO-2/3 binding profiles together with the potential role of chromatin SUMOylation in transcription regulation. This was carried out via high-throughput sequencing analysis. Interestingly, chromatin immunoprecipitation sequencing (ChIP-seq) experiments showed that KSHV reactivation is accompanied by a significant increase in SUMO-2/3 modification around promoter regions, but SUMO-1 enrichment was absent. Expression profiling revealed that the SUMO-2/3 targeted genes are primarily highly transcribed genes that show no expression changes during viral reactivation. Gene ontology analysis further showed that these genes are involved in cellular immune responses and cytokine signaling. High-throughput annotation of SUMO occupancy of transcription factor binding sites (TFBS) pinpointed the presence of three master regulators of immune responses, IRF-1, IRF-2, and IRF-7, as potential SUMO-2/3 targeted transcriptional factors after KSHV reactivation. CONCLUSION: Our study is the first to identify differential genome-wide SUMO modifications between SUMO paralogues during herpesvirus reactivation. Our findings indicate that SUMO-2/3 modification near protein-coding gene promoters occurs in order to maintain host immune-related gene unaltered during viral reactivation.
format Online
Article
Text
id pubmed-4046822
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40468222014-06-06 The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation Chang, Pei-Ching Cheng, Chia-Yang Campbell, Mel Yang, Yi-Cheng Hsu, Hung-Wei Chang, Ting-Yu Chu, Chia-Han Lee, Yi-Wei Hung, Chiu-Lien Lai, Shi-Mei Tepper, Clifford G Hsieh, Wen-Ping Wang, Hsei-Wei Tang, Chuan-Yi Wang, Wen-Ching Kung, Hsing-Jien BMC Genomics Research Article BACKGROUND: SUMOylation, as part of the epigenetic regulation of transcription, has been intensively studied in lower eukaryotes that contain only a single SUMO protein; however, the functions of SUMOylation during mammalian epigenetic transcriptional regulation are largely uncharacterized. Mammals express three major SUMO paralogues: SUMO-1, SUMO-2, and SUMO-3 (normally referred to as SUMO-1 and SUMO-2/3). Herpesviruses, including Kaposi’s sarcoma associated herpesvirus (KSHV), seem to have evolved mechanisms that directly or indirectly modulate the SUMO machinery in order to evade host immune surveillance, thus advancing their survival. Interestingly, KSHV encodes a SUMO E3 ligase, K-bZIP, with specificity toward SUMO-2/3 and is an excellent model for investigating the global functional differences between SUMO paralogues. RESULTS: We investigated the effect of experimental herpesvirus reactivation in a KSHV infected B lymphoma cell line on genomic SUMO-1 and SUMO-2/3 binding profiles together with the potential role of chromatin SUMOylation in transcription regulation. This was carried out via high-throughput sequencing analysis. Interestingly, chromatin immunoprecipitation sequencing (ChIP-seq) experiments showed that KSHV reactivation is accompanied by a significant increase in SUMO-2/3 modification around promoter regions, but SUMO-1 enrichment was absent. Expression profiling revealed that the SUMO-2/3 targeted genes are primarily highly transcribed genes that show no expression changes during viral reactivation. Gene ontology analysis further showed that these genes are involved in cellular immune responses and cytokine signaling. High-throughput annotation of SUMO occupancy of transcription factor binding sites (TFBS) pinpointed the presence of three master regulators of immune responses, IRF-1, IRF-2, and IRF-7, as potential SUMO-2/3 targeted transcriptional factors after KSHV reactivation. CONCLUSION: Our study is the first to identify differential genome-wide SUMO modifications between SUMO paralogues during herpesvirus reactivation. Our findings indicate that SUMO-2/3 modification near protein-coding gene promoters occurs in order to maintain host immune-related gene unaltered during viral reactivation. BioMed Central 2013-11-23 /pmc/articles/PMC4046822/ /pubmed/24267727 http://dx.doi.org/10.1186/1471-2164-14-824 Text en © Chang et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chang, Pei-Ching
Cheng, Chia-Yang
Campbell, Mel
Yang, Yi-Cheng
Hsu, Hung-Wei
Chang, Ting-Yu
Chu, Chia-Han
Lee, Yi-Wei
Hung, Chiu-Lien
Lai, Shi-Mei
Tepper, Clifford G
Hsieh, Wen-Ping
Wang, Hsei-Wei
Tang, Chuan-Yi
Wang, Wen-Ching
Kung, Hsing-Jien
The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation
title The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation
title_full The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation
title_fullStr The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation
title_full_unstemmed The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation
title_short The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation
title_sort chromatin modification by sumo-2/3 but not sumo-1 prevents the epigenetic activation of key immune-related genes during kaposi’s sarcoma associated herpesvirus reactivation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046822/
https://www.ncbi.nlm.nih.gov/pubmed/24267727
http://dx.doi.org/10.1186/1471-2164-14-824
work_keys_str_mv AT changpeiching thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT chengchiayang thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT campbellmel thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT yangyicheng thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT hsuhungwei thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT changtingyu thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT chuchiahan thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT leeyiwei thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT hungchiulien thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT laishimei thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT teppercliffordg thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT hsiehwenping thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT wanghseiwei thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT tangchuanyi thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT wangwenching thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT kunghsingjien thechromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT changpeiching chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT chengchiayang chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT campbellmel chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT yangyicheng chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT hsuhungwei chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT changtingyu chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT chuchiahan chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT leeyiwei chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT hungchiulien chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT laishimei chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT teppercliffordg chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT hsiehwenping chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT wanghseiwei chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT tangchuanyi chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT wangwenching chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation
AT kunghsingjien chromatinmodificationbysumo23butnotsumo1preventstheepigeneticactivationofkeyimmunerelatedgenesduringkaposissarcomaassociatedherpesvirusreactivation